Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics

Drug Metabolism and Drug Interactions

Volumn 17, Issue 1-4, 2000, Pages 311-349

  Galati, G ^a   Teng, S ^a   Moridani, M Y ^a   Chan, T S ^a   O'Brien, P J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antioxidants; Bioflavonoids; Cancer chemoprevention; Capsaicin; Coumaric acids; Curcumin; Flavones; Hepatocytes; Herbal medicine; Safety; Stilbenes; Tumour cell apoptosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHOCYANIN; APIGENIN; BENZOIC ACID DERIVATIVE; BIOCHANIN A; CAFFEIC ACID; CATECHIN; CELL DNA; CHRYSIN; COUMARIC ACID; DNA TOPOISOMERASE; ELLAGIC ACID; ERIODICTYOL; FERULIC ACID; FISETIN; FLAVONOID; FLAVONOL DERIVATIVE; FLAVOPIRIDOL; GALANGIN; GALLIC ACID; HESPERETIN; KAEMPFEROL; LUTEOLIN; MORIN; NARINGENIN; ORNITHINE DECARBOXYLASE; PHLORETIN; POLYAMINE DERIVATIVE; POLYPHENOL DERIVATIVE; RESVERATROL; STILBENE DERIVATIVE; TAXIFOLIN; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; DNA SYNTHESIS; DRUG STRUCTURE; ENZYME ACTIVITY; FOOD COMPOSITION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; POLYAMINE SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034519306     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2000.17.1-4.311     Document Type: Review

References (132)

1. Dietary fiber, vegetables, and colon cancer: Critical review and meta-analyses of the epidemiological evidence
2. Tea flavonols in cardiovascular disease and cancer epidemiology
3. Nutraceuticals and functional foods: Introduction and meaning
4. Antioxidants and cancer: Molecular mechanisms
5. Bioavailability of flavonoids
6. Bioavailability of flavonoids and potential bioactive forms in vivo
7. Bioavailability of rutin and quercetin in rats
8. Accumulation of epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues
9. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays
10. Tea and health: The underlying mechanisms
11. Contribution of caffeine and flavanols in the induction of phase II activities by green tea
12. Induction of phase II enzymes by green tea polyphenols
13. Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens
14. Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids
15. Cancer chemopreventive activity mediated by 4′-bromoflavone, a potent inducer of Phase II detoxification enzymes
16. Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice
17. Polyphenols as cancer chemopreventive agents
18. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes
19. Ellagic acid induces transcription of the rat glutathione-S-transferase Ya gene
20. Biodistribution of antimutagenic efficiencies and inhibition of P450 activities by ellagic acid
21. CAPE stimulates human antioxidant response element-mediated expression of the NAD(P)H:quinone reductase (NQO1) gene
22. Capsaicin, a double-edged sword: Toxicity, metabolism and chemopreventive potential
23. Chemopreventive effects of capsaicin against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine
24. Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes
25. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation
26. Inhibition by dietary curcumin of azoxymethane-induced omithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon
27. Rosemary extract and camosol stimulate rat liver glutathione-S-transferase and quinone reductase activities
28. Cancer chemopreventive activity of resveratrol
29. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
30. Resveratrol is a selective human cytochrome P450 1A1 inhibitor
31. Chemoprevention for colorectal cancer
32. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in SENCAR mouse skin tumorigenesis model
33. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols
34. Growth inhibition and regression of human prostate and breast tumors in athymic mice by daily tea epigallocatechin gallate
35. Effects of oral administration of tea and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light
36. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cycloxygenase-2 in human oral epithelial cells and in a rat model of inflammation
37. Chemoprevention of colon carcinogenesis by phenylethyl-3-methyl caffeate
38. Inhibitory effects of CAPE on TPA induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells
39. Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester
40. Inhibitory effects of flavonoids on xanthine oxidase
41. Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition
42. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II
43. Antitumor effects of Scutellariae radix and its components baicalein, baicalin and wagonin on bladder cancer cell lines
44. Lipoxygenase inhibition induced apoptosis in human pancreatic cancer cells
45. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
46. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells
47. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
48. Inhibition of benzoyl peroxide-mediated tumor promotion in DMBA-initiated skin of SENCAR mice by antioxidants nordihydroguaiaretic acid and dialkyl sulfide
49. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
50. 2 release in adherant human neutrophils
51. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice
52. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone and quercetin
53. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperetin
54. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin
55. Milk thistle for the therapy of liver disease
56. Protective effects of silymarin against photocarcinogenesis in a mouse skin model
57. Inhibitory effect of silymarin, an antihepatotoxic flavonoid, on phorbol ester induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice
58. Inhibitory effects of semisynthetic flavonoid derivatives on the biochemical markers of tumor promotion in mouse epidermis in vivo
59. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound
60. Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid
61. Chemopreventive effects of ferulic acid on oral carcinogenesis
62. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase
63. NADH: Ubiquinone oxidoreductase inhibitors block induction of ornithine decarboxylase activity in MCF-7 human breast cancer cells
64. Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone
65. Inhibition of mitochondrial function by flavonoids
66. Biochemical targets of the isoflavone genistein in tumor cell lines
67. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor
68. Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships
69. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices
70. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression
71. Structural studies on bioactive compounds. 23. Comparison of their cytotoxicities and pharmacological properties with genistein and quercetin
72. Structural requirements for growth-inhibition of mouse erythroleukemia cells by isoflavones
73. Genistein inhibits proliferation similarly in estrogen receptor-postive and -negative human breast carcinoma cell lines
74. Site-directed 8-Cl-cAMP as a biologic modulator of cancer: Restoration of normal control mechanisms
75. Modulation of cAMP levels in a neural cell line by inhibitors of tyrosine phosphorylation
76. Endothelium-dependent relaxation of rat aorta by butein, a novel cAMP-specific phosphodiesterase inhibitor
77. Tyrosine kinase-independent inhibition of cAMP phosphodiesterase by genistein and tyrphostin 5
78. Inhibition of rat liver cAMP dependent protein kinase by flavonoids
79. Phosphoinositide 3-kinases: A conserved family of signal transducers
80. 3-kinase
81. Relationship between flavonoid structure and inhibition of phosphatidylinositol-3 kinase: A comparison with tyrosine kinase and protein kinase C inhibition
82. Molecular mechanisms in the antiproliferative action of quercetin
83. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells
84. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin
85. Activation of mitogen-activated protein kinases by green tea polyphenols: Potential signaling pathways in the regulation of antioxidant-responsive-element-mediated phase II enzyme gene expression
86. Flavopiridol binds to duplex DNA
87. 2/M and growth inhibition by apigenin in human colon carcinoma cell lines
88. Differential effects on growth, cell cycle arrest and induction of apoptosis by resveratrol in human prostate cancer cell lines
89. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
90. DNA polymerase and topoisomerase inhibitors
91. Flavonoids activate wild-type p53
92. p53-independent apoptosis induced by genistein in lung cancer cells
93. Cell death induced by baicalein in human hepatocellular carcinoma cell lines
94. Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells
95. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukemia HL-60 cells
96. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells
97. Mitochondrial respiratory chain inhibitors induce apoptosis
98. The mitochondrion in cell death control: Certainties and incognita
99. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis
100. Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid
101. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines
102. The effect of flavonoids on aerobic glycolysis and growth of tumor cells
103. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
104. Effect of naturally occurring flavonoids on lipid peroxidation and membrane permeability transition in mitochondria
105. Flavonoids of honey and propolis: Characterisation and effects on hepatic drug-metabolising enzymes and benzo(a)pyrene-DNA binding in rats
106. Anticlastogenic effect of flavonoids against mutagen-induced micronuclei in mice
107. Antigenotoxicity of galangin against N-methyl-N-nitrosourea
108. The flavonoid galangin is an inhibitor of CYP1A1 activity and an antagonist/agonist of the aryl hydrocarbon receptor
109. Mechanism of the inhibitory action of capsaicin on energy metabolism by rat liver mitochondria
110. Inhibition of mitochondrial electron transport by NDGA
111. 1-ATPase/ATP synthase by polyphenolic phytochemicals
112. Uncoupling and inhibition of the respiratory chain in rat liver mitochondria by some naturally occurring estrogens and their metabolites
113. Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells
114. Uncoupling activity of a series of flavones and flavonols on isolated plant mitochondria
115. In vitro biotransformation of flavonoids by rat liver microsomes
116. Active oxygen generation by flavonoids
117. Induction of oxidative stress by redox active flavonoids
118. Triggering and modulation of apoptosis by oxidative stress
119. Regulation of reactive oxygen species induced apoptosis and necrosis by caspase-3-like protease
120. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates
121. Inhibition of arachidonaate 5 lipoxygenase triggers massive apoptosis in human prostate cancer cells
122. Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: Involvement of oxidative stress
123. Induction of apoptosis in breast cancer cell MDA-MB-231 by genistein
124. cAMP-mediated signals as determinants for apoptosis in primary granulosa
125. Side effects of flavonoids in medical practice
126. Is quercetin carcinogenic?
127. Potential health impacts of excessive flavonoid intake
128. Cytotoxicity of plant flavonoids against HeLa cells
129. 2+
130. A quantum chemical explanation of the antioxidant activity of flavonoids
131. Crystal structure of phlorizin and the iodothyronine deiodinase inhibitory activity of phloretin analogues